• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童脑肿瘤中分子遗传标志物的预后意义

Prognostic significance of molecular genetic markers in childhood brain tumors.

作者信息

Cogen P H

机构信息

Department of Neurological Surgery, School of Medicine, University of California, San Francisco.

出版信息

Pediatr Neurosurg. 1991;17(5):245-50. doi: 10.1159/000120605.

DOI:10.1159/000120605
PMID:1668360
Abstract

Molecular genetic analysis of several common cancers has yielded information concerning their etiology and prognosis. Restriction fragment length polymorphism (RFLP) studies showing consistent loss of specific DNA sequences in tumor tissue have identified genes, known as tumor suppressors, associated with the etiology of neoplasms of the adult colon, breast, lung, and brain. For several of these tumors, identifiable mutations of these genes in association with multiple chromosomal losses have been linked to a poor clinical outcome. Using RFLP and other techniques, we have determined that one or more tumor suppressor genes on chromosome 17p is involved in the etiology of both medulloblastoma and astrocytoma in children. Loss of chromosome 17p sequences is indicative of prognosis negative for these children. Molecular genetic data therefore supplement and in some cases surpass clinical criteria in predicting prognosis for these childhood tumors.

摘要

对几种常见癌症的分子遗传学分析已得出有关其病因和预后的信息。限制性片段长度多态性(RFLP)研究表明肿瘤组织中特定DNA序列持续缺失,从而确定了与成人结肠、乳腺、肺和脑肿瘤病因相关的基因,即肿瘤抑制基因。对于其中几种肿瘤,这些基因的可识别突变与多条染色体缺失相关,已被证明与不良临床结果有关。利用RFLP和其他技术,我们已确定17号染色体短臂上的一个或多个肿瘤抑制基因参与儿童髓母细胞瘤和星形细胞瘤的病因。17号染色体短臂序列的缺失表明这些儿童的预后不良。因此,分子遗传学数据在预测这些儿童肿瘤的预后方面补充了临床标准,在某些情况下甚至超越了临床标准。

相似文献

1
Prognostic significance of molecular genetic markers in childhood brain tumors.儿童脑肿瘤中分子遗传标志物的预后意义
Pediatr Neurosurg. 1991;17(5):245-50. doi: 10.1159/000120605.
2
Deletion mapping of the medulloblastoma locus on chromosome 17p.17号染色体短臂上髓母细胞瘤基因座的缺失定位
Genomics. 1990 Oct;8(2):279-85. doi: 10.1016/0888-7543(90)90283-z.
3
Tumor suppressor genes and medulloblastoma.肿瘤抑制基因与髓母细胞瘤
J Neurooncol. 1996 Jul;29(1):103-12. doi: 10.1007/BF00165523.
4
Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.染色体臂17p缺失分析揭示了中枢神经系统幕上和幕下原始神经外胚层肿瘤的分子遗传异质性。
Cancer Genet Cytogenet. 1997 Aug;97(1):25-31. doi: 10.1016/s0165-4608(96)00319-6.
5
Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.散发性儿童室管膜瘤中17号染色体短臂和22号染色体长臂DNA序列的分子遗传学分析
Genes Chromosomes Cancer. 1996 Sep;17(1):37-44. doi: 10.1002/(SICI)1098-2264(199609)17:1<37::AID-GCC6>3.0.CO;2-3.
6
Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.17号染色体p臂缺失在儿童中枢神经系统原始神经外胚层肿瘤(髓母细胞瘤)中的预后意义
Clin Cancer Res. 1997 Mar;3(3):473-8.
7
Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.
Am J Hum Genet. 1992 Mar;50(3):584-9.
8
[Chromosome abnormalities and tumor suppressor gene in childhood cancer].[儿童癌症中的染色体异常与肿瘤抑制基因]
Gan To Kagaku Ryoho. 1990 Dec;17(12):2327-32.
9
[Tumor suppressor genes: occurrence, significance and function].[肿瘤抑制基因:发生、意义及功能]
Monatsschr Kinderheilkd. 1991 Oct;139(10):650-4.
10
Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.人类中枢神经系统原始神经外胚层肿瘤中6号染色体长臂、16号染色体长臂和17号染色体短臂的杂合性缺失
Cancer Res. 1991 Jan 15;51(2):639-43.

引用本文的文献

1
Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.通过全基因组拷贝数谱分析鉴定小儿髓母细胞瘤中的新型扩增。
J Neurooncol. 2012 Mar;107(1):37-49. doi: 10.1007/s11060-011-0716-0. Epub 2011 Oct 7.
2
Recent advances in embryonal tumours of the central nervous system.中枢神经系统胚胎性肿瘤的最新进展
Childs Nerv Syst. 2005 Apr;21(4):272-93. doi: 10.1007/s00381-004-1066-4. Epub 2005 Jan 29.
3
Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.
髓母细胞瘤中17号染色体p13.1 - 13.3区域杂合性缺失分析及其与临床结局的相关性
J Neurooncol. 2004 Mar-Apr;67(1-2):41-6. doi: 10.1023/b:neon.0000021773.71127.fb.
4
Clinical and molecular stratification of disease risk in medulloblastoma.髓母细胞瘤疾病风险的临床与分子分层
Br J Cancer. 2001 Sep 1;85(5):705-12. doi: 10.1054/bjoc.2001.1987.
5
The molecular biology of ependymomas.室管膜瘤的分子生物学
Brain Pathol. 1997 Apr;7(2):807-22. doi: 10.1111/j.1750-3639.1997.tb01066.x.
6
Tumor suppressor genes and medulloblastoma.肿瘤抑制基因与髓母细胞瘤
J Neurooncol. 1996 Jul;29(1):103-12. doi: 10.1007/BF00165523.
7
Prognostic implications of chromosome 17p deletions in human medulloblastomas.人类髓母细胞瘤中17号染色体短臂缺失的预后意义
J Neurooncol. 1995;24(1):39-45. doi: 10.1007/BF01052657.